Abstract A47: DNA-PKcs is amplified in high-grade serous ovarian cancer (HGSC), correlates with poor outcome and drives resistance to platinum therapy via the AKT signaling pathway
Abstract A47: DNA-PKcs is amplified in high-grade serous ovarian cancer (HGSC), correlates with poor outcome and drives resistance to platinum therapy via the AKT signaling pathway
复制标题
摘要 A47：DNA-PKcs 在高级别浆液性卵巢癌 (HGSC) 中扩增，与不良预后相关，并通过 AKT 信号通路驱动对铂类治疗的耐药性
DOI：
10.1158/1538-8514.pi3k14-a47
复制
发表时间：
2015
影响因子：
5.7
通讯作者：
Curry E
中科院分区：
文献类型：
--
作者：
Curry E
